U.S. Markets close in 1 hr 18 mins
  • S&P 500

    4,142.11
    -21.18 (-0.51%)
     
  • Dow 30

    34,175.84
    -151.95 (-0.44%)
     
  • Nasdaq

    13,350.22
    -28.83 (-0.22%)
     
  • Russell 2000

    2,233.70
    +6.58 (+0.30%)
     
  • Crude Oil

    65.49
    -0.78 (-1.18%)
     
  • Gold

    1,869.60
    +2.00 (+0.11%)
     
  • Silver

    28.37
    +0.10 (+0.34%)
     
  • EUR/USD

    1.2231
    +0.0074 (+0.6115%)
     
  • 10-Yr Bond

    1.6490
    +0.0090 (+0.55%)
     
  • Vix

    20.03
    +0.31 (+1.57%)
     
  • GBP/USD

    1.4187
    +0.0050 (+0.3533%)
     
  • USD/JPY

    108.8840
    -0.3160 (-0.2894%)
     
  • BTC-USD

    42,615.80
    -843.90 (-1.94%)
     
  • CMC Crypto 200

    1,192.74
    -60.40 (-4.82%)
     
  • FTSE 100

    7,034.24
    +1.39 (+0.02%)
     
  • Nikkei 225

    28,406.84
    +582.01 (+2.09%)
     

Moving Average Crossover Alert: Chemed Corp (CHE)

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Chemed Corporation CHE could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for CHE broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.

This has already started to take place, as the stock has moved lower by 2.6% in the past four weeks. And with the recent moving average crossover, investors have to think that more unfavorable trading is ahead for CHE stock.

If that wasn’t enough, CHE isn’t looking too great from an earnings estimate revision perspective either. It appears as though many analysts have been reducing their earnings expectations for the stock lately, which is usually not a good sign of things to come.

Consider that in the last 30 days, 2 estimates have been reduced, while none has moved higher. Add this in to a similar move lower in the consensus estimate, and there is plenty of reason to be bearish here.

That is why we currently have a Zacks Rank #5 (Strong Sell) on this stock and are looking for it to underperform in the weeks ahead. So, either avoid this stock or consider jumping ship until the estimates and technical factors turn around for CHE. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in deCHEd for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chemed Corporation (CHE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research